Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease

摘要: Clinical use of genetic testing to predict adult onset conditions allows individuals minimize or circumvent disease when preventive medical interventions are available. Recent policy recommendations and changes expand patient access information about asymptomatic create mechanisms for expanded insurance coverage tests. The American College Medical Genetics Genomics (ACMG) recommends that laboratories provide incidental findings medically actionable variants after whole genome sequencing. Patient Protection Affordable Care Act (ACA) established mandate tests, such as BRCA. ACA ACMG, however, do not address interventions. These policies equate prevention, without exploring the accessibility affordability In reality, in adults is variable given US health system's focus on treatment. Health disparities will be exacerbated if only privileged segments society can interventions, prophylactic surgeries, screenings, medication. To ensure equitable federal state legislatures should both predictive recommended follow-up included a list by an expert panel regulatory body.